Predicting Residence Time and Drug Unbinding Pathway through Scaled Molecular Dynamics
- 30 November 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 59 (1) , 535-549
Abstract
Computational approaches currently assist medicinal chemistry through the entire drug discovery pipeline. However, while several computational tools and strategies are available to predict binding affinity, predicting the drug-target binding kinetics is still a matter of ongoing research. Here, we challenge scaled Molecular Dynamics simulations to assess the off-rates for a series of structurally diverse inhibitors of the heat shock protein 90 (Hsp90) covering three orders of magnitude in their experimental residence times. The derived computational predictions are in overall good agreement with experimental data. Aside from the estimation of exit times, unbinding pathways were assessed through dimensionality reduction techniques. The data analysis framework proposed in this work could lead to better understanding of the mechanistic aspects related to the observed kinetic behavior.Keywords
Funding Information
- FP7 Joint Technology Initiatives (1115366)
- European Federation of Pharmaceutical Industries and Associations (1115366)
This publication has 84 references indexed in Scilit:
- Kinetics for Drug Discovery: an industry-driven effort to target drug residence timeDrug Discovery Today, 2017
- Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA InhibitorsJournal of the American Chemical Society, 2017
- Protein–ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modellingMedChemComm, 2017
- The drug–target residence time model: a 10-year retrospectiveNature Reviews Drug Discovery, 2015
- On-rate based optimization of structure–kinetic relationship – surfing the kinetic mapDrug Discovery Today: Technologies, 2015
- Applying thermodynamic profiling in lead finding and optimizationNature Reviews Drug Discovery, 2015
- Molecular determinants of drug–receptor binding kineticsDrug Discovery Today, 2013
- Structure and dynamics of the M3 muscarinic acetylcholine receptorNature, 2012
- Drug–target residence time: critical information for lead optimizationCurrent Opinion in Chemical Biology, 2010
- Drug–target residence time and its implications for lead optimizationNature Reviews Drug Discovery, 2006